Mass Treatment with Single-Dose Azithromycin for Trachoma | Zendy

Anthony W. Solomon | Zendy; Martin J. Holland | Zendy; Neâl Alexander | Zendy; Patrick Massae | Zendy; Aura Aguirre | Zendy; Angels Natividad-Sancho | Zendy; Sandra Molina | Zendy; Salesia Safari | Zendy; John F. Shao | Zendy; Paul Courtright | Zendy; Rosanna W. Peeling | Zendy; Sheila K. West | Zendy; Robin L. Bailey | Zendy; Allen Foster | Zendy; David Mabey | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mass Treatment with Single-Dose Azithromycin for Trachoma

Author(s) -

Anthony W. Solomon,

Martin J. Holland,

Neâl Alexander,

Patrick Massae,

Aura Aguirre,

Angels Natividad-Sancho,

Sandra Molina,

Salesia Safari,

John F. Shao,

Paul Courtright,

Rosanna W. Peeling,

Sheila K. West,

Robin L. Bailey,

Allen Foster,

David Mabey

Publication year - 2004

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa040979

Subject(s) - azithromycin , trachoma , medicine , dermatology , microbiology and biotechnology , antibiotics , biology , pathology

Trachoma, caused by repeated ocular infection with Chlamydia trachomatis, is an important cause of blindness. Current recommended dosing intervals for mass azithromycin treatment for trachoma are based on a mathematical model.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore